Ironwood Pharmaceuticals Ownership | Who Owns Ironwood Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Ironwood Pharmaceuticals Ownership Summary


Ironwood Pharmaceuticals is owned by 100.25% institutional investors, 3.24% insiders. Blackrock is the largest institutional shareholder, holding 14.51% of IRWD shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.66% of its assets in Ironwood Pharmaceuticals shares.

IRWD Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockIronwood Pharmaceuticals100.25%3.24%-3.48%
SectorHealthcare Stocks 244.59%12.11%-156.70%
IndustrySpecialty & Generic Drug Manufacturers Stocks37.12%13.99%48.89%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock22.88M14.51%$149.16M
Blackrock funding, inc. /de17.79M10.88%$74.89M
Vanguard group15.96M9.84%$53.78M
Armistice capital13.93M8.52%$58.65M
Sarissa capital management lp9.19M5.62%$38.68M
State street8.81M5.39%$37.09M
Bank of america corp /de/8.68M5.31%$36.56M
Renaissance7.99M4.89%$33.65M
Vanguard capital management6.61M4.04%$27.82M
Aqr capital management6.47M3.96%$27.22M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Sarissa capital management lp9.19M21.75%$38.68M
Cm management350.00K0.94%$1.47M
Armistice capital13.93M0.72%$58.65M
Kynam capital management, lp5.47M0.53%$7.16M
Virtus investment advisers318.60K0.31%$1.34M
Optimist retirement group102.05K0.17%$429.65K
Globeflex capital l p259.81K0.14%$1.09M
Hillsdale investment management1.25M0.12%$5.26M
Inspire investing630.07K0.11%$2.65M
Gsa capital partners llp259.51K0.07%$1.09M

Top Buyers

HolderShares% AssetsChange
Blackrock funding, inc. /de17.79M0.00%4.43M
Sixth street partners management company3.30M0.00%3.30M
Mackenzie financial2.37M0.01%1.81M
State street8.81M0.00%1.35M
Wells fargo & company/mn1.21M0.00%1.15M

Top Sellers

HolderShares% AssetsChange
Braidwell lp---6.62M
Brown capital management---2.58M
Point72 asset management---1.53M
Charles schwab investment management3.30M0.00%-1.44M
Glenmede trust co na---1.40M

New Positions

HolderShares% AssetsChangeValue
Sixth street partners management company3.30M0.00%3.30M$13.90M
Hrt financial lp577.34K0.00%577.34K$2.43M
Cwa asset management group290.37K0.04%290.37K$1.22M
Norges bank252.29K0.00%252.29K$1.12M
Cubist systematic strategies53.99K0.00%53.99K$70.73K

Sold Out

HolderChange
Natixis-2.00
Jfs wealth advisors-10.00
Mendota financial group-11.00
Dinuzzo private wealth-15.00
Nelson, van denburg & campbell wealth management group-26.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2026219-6.41%163,855,1861.48%1001.01%98-31.47%8353.70%
Mar 31, 202623012.75%160,024,9363.50%981.09%13815.00%5414.89%
Dec 31, 2025151-10.12%107,820,680-27.61%660.78%85-2.30%38-13.64%
Sep 30, 20251608.84%148,842,9659.30%921.30%829.33%43-4.44%
Jun 30, 2025153-24.26%146,234,9095.06%901.21%76-27.62%49-20.97%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF9.06M5.66%-
State Street® SPDR® S&P® Biotech ETF5.41M3.28%12.43K
Vanguard Total Stock Mkt Idx Inv4.78M2.90%446.70K
Vanguard Morn Total Stk Mkt Idx Investor4.78M2.90%446.70K
Vanguard MStar Total Stk Mkt Idx Invest4.78M2.89%-
Vanguard US Total Market Shares ETF4.18M2.59%-
iShares Russell 2000 ETF4.17M2.52%-74.02K
SPDR® S&P Biotech ETF2.51M1.57%-15.31K
Vanguard Small Cap Index1.74M1.09%1.41K
Vanguard Strategic Equity Inv1.75M1.06%-350.74K

Recent Insider Transactions


DateNameRoleActivityValue
Jul 07, 2026Silver Ronald PFO & PAOSell$578.06K
Jun 16, 2026McHugh Julie-Sell$80.46K
Mar 17, 2026DENNER ALEXANDER J-Sell$20.51M
Mar 17, 2026DENNER ALEXANDER J-Sell$19.20K
Feb 23, 2026John Minardo Chief Legal OfficerSell$66.44K

Insider Transactions Trends


DateBuySell
2026 Q3-1
2026 Q2-1
2026 Q1-15
2025 Q4-1
2025 Q3-4

IRWD Ownership FAQ


Who Owns Ironwood Pharmaceuticals?

Ironwood Pharmaceuticals shareholders are primarily institutional investors at 100.25%, followed by 3.24% insiders and -3.49% retail investors. The average institutional ownership in Ironwood Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 37.12%, which Ironwood Pharmaceuticals exceeds.

Who owns the most shares of Ironwood Pharmaceuticals?

Ironwood Pharmaceuticals’s largest shareholders are Blackrock (22.88M shares, 14.51%), Blackrock funding, inc. /de (17.79M shares, 10.88%), and Vanguard group (15.96M shares, 9.84%). Together, they hold 35.23% of Ironwood Pharmaceuticals’s total shares outstanding.

Does Blackrock own Ironwood Pharmaceuticals?

Yes, BlackRock owns 14.51% of Ironwood Pharmaceuticals, totaling 22.88M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 149.16M$. In the last quarter, BlackRock decreased its holdings by -1.281M shares, a -5.30% change.

Who is Ironwood Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Sarissa capital management lp is Ironwood Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 21.75% of its assets in 9.19M Ironwood Pharmaceuticals shares, valued at 38.68M$.

Who is the top mutual fund holder of Ironwood Pharmaceuticals shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Ironwood Pharmaceuticals shares, with 5.66% of its total shares outstanding invested in 9.06M Ironwood Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools